Introduction.
The role of aseptic inflammation and disturbances in the hemostasis and fibrinolysis systems has been demonstrated in the pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH); however, the profile and direction of changes in circulating markers vary significantly across studies, reflec...
M. Simakova, Y. Karpova, A. M. Osadchii et al.· Siberian Journal of Clinical...· 0 citations
Controllable pulmonary thromboendarterectomy provides objective intraoperative assessment of completeness of PEA without prolonged circulatory arrest time and Hemodynamic, clinical and functional outcomes are consistent with the best international standards.
A. M. Osadchii, I. Zugurov, M. Simakova et al.· Khirurgiia· 0 citations
Aim
. To characterize the phenotypic characteristics and diagnostic principles of various variants of amyloid cardiomyopathy based on local registry data.
Material and methods
. From 2017 to 2025, 195 patients with suspected cardiac amyloidosis were examined. The diagnosis was verified in 103 patients. Transt...
P. Murtazalieva, D. D. Vakunenkova, D. Ryzhkova et al.· Russian Journal of Cardiolog...· 0 citations
Aim
.
To characterize the pregnancy and postpartum period in carriers of truncating
TTN
gene variants with a phenotype of dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) with increased left ventricular (LV) trabeculation, and to evaluate the potential role of pregnancy as a trigger for deco...
I. S. Danilevich, E. Karelkina, A. Ryzhkov et al.· Russian Journal of Cardiolog...· 0 citations
Aim
.
To determine whether pregnancy is associated with a worsened clinical course and long-term prognosis in patients with hypertrophic cardiomyopathy (HCM), and to evaluate differences in maternal, obstetric, and cardiovascular outcomes between obstructive and non-obstructive disease forms.
Material
and m...
A. A. Nikolaeva, E. Karelkina, V. Zaytsev et al.· Russian Journal of Cardiolog...· 0 citations
Goflikicept effectively normalized dysregulated immune responses in IRP, supporting the broader therapeutic potential of IL-1 blockade in NLRP3-mediated inflammatory diseases.
A. Golovkin, E. Markelova, E. Ignatieva et al.· Inflammation Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.